PMID- 36946380 OWN - NLM STAT- MEDLINE DCOM- 20230712 LR - 20230718 IS - 1744-5094 (Electronic) IS - 1381-6810 (Linking) VI - 44 IP - 4 DP - 2023 Aug TI - Self-reported visual function and psychosocial impact of visual loss in EYS-associated retinal degeneration in a Portuguese population. PG - 334-340 LID - 10.1080/13816810.2023.2191708 [doi] AB - PURPOSE: To evaluate self-reported visual function and the psychosocial impact of visual loss EYS-associated retinal degeneration (EYS-RD) using two patient-reported outcome (PRO) measures: Michigan Retinal Degeneration Questionnaire (MRDQ) and Michigan Vision-related Anxiety Questionnaire (MVAQ). METHODS: Cross-sectional, single-center study conducted at a tertiary care hospital in Portugal. Patients with biallelic EYS variants were invited to participate. Clinical data including demographics, ETDRS best-corrected visual acuity (BCVA) in the better-seeing eye and genetic testing results were collected. Interviews were carried out during clinic visits or by phone between November 2021 and February 2022. A blind grader used horizontal and vertical spectral domain optical coherence tomography (SD-OCT) scans to manually measure ellipsoid zone (EZ) width in the nasal, temporal, superior and inferior macular quadrants to calculate the EZ area. RESULTS: Forty-nine patients (53.1% males; mean age 53 +/- 14 years) were included. A positive correlation (p < .05) was found between age and most MRDQ domain scores (central vision, color vision, contrast sensitivity, scotopic function, photopic peripheral vision and mesopic peripheral vision). A negative correlation was found between both BCVA and EZ area across all MRDQ domains. In MVAQ, SD-OCT EZ area negatively correlated with both rod function and cone function-related anxiety. Neither age, BCVA or gender correlated with MVAQ domains. CONCLUSIONS: This study provides strong evidence supporting a correlation between PRO measures and both functional and structural clinician-reported outcomes. The use of MRDQ and MVAQ adds a new dimension to our understanding of EYS-RD and establishes both PRO measures as important disease outcome measures. FAU - Marques, Joao Pedro AU - Marques JP AUID- ORCID: 0000-0002-1014-0483 AD - Ophthalmology Unit, Centro Hospitalar e Universitario de Coimbra (CHUC), Coimbra, Portugal. AD - Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal. AD - Faculty of Medicine, University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal. AD - Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. AD - University Clinic of Ophthalmology, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal. FAU - Machado Soares, Ricardo AU - Machado Soares R AD - Department of Ophthalmology, Centro Hospitalar de Vila Nova de Gaia e Espinho (CHVNGE), Gaia, Portugal. FAU - Simao, Silvia AU - Simao S AD - Ophthalmology Unit, Centro Hospitalar e Universitario de Coimbra (CHUC), Coimbra, Portugal. FAU - Abuzaitoun, Rebhi AU - Abuzaitoun R AD - Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA. FAU - Andrews, Chris AU - Andrews C AD - Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA. FAU - Alves, C Henrique AU - Alves CH AD - Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal. AD - Faculty of Medicine, University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal. AD - Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. AD - Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal. FAU - Ambrosio, Antonio Francisco AU - Ambrosio AF AD - Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal. AD - Faculty of Medicine, University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal. AD - Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. AD - Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, Coimbra, Portugal. FAU - Murta, Joaquim AU - Murta J AD - Ophthalmology Unit, Centro Hospitalar e Universitario de Coimbra (CHUC), Coimbra, Portugal. AD - Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal. AD - Faculty of Medicine, University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal. AD - Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. AD - University Clinic of Ophthalmology, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal. FAU - Silva, Rufino AU - Silva R AD - Ophthalmology Unit, Centro Hospitalar e Universitario de Coimbra (CHUC), Coimbra, Portugal. AD - Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal. AD - Faculty of Medicine, University of Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal. AD - Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal. AD - University Clinic of Ophthalmology, Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal. FAU - Abalem, Maria Fernanda AU - Abalem MF AD - Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA. AD - Department of Ophthalmology and Otolaryngology, University of Sao Paulo Medical School, Sao Paulo, Brazil. FAU - Jayasundera, K Thiran AU - Jayasundera KT AD - Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan, USA. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20230322 PL - England TA - Ophthalmic Genet JT - Ophthalmic genetics JID - 9436057 RN - 0 (EYS protein, human) RN - 0 (Eye Proteins) SB - IM MH - Male MH - Humans MH - Adult MH - Middle Aged MH - Aged MH - Female MH - *Retinal Degeneration/genetics MH - Portugal MH - Self Report MH - Cross-Sectional Studies MH - Visual Acuity MH - Vision Disorders MH - Tomography, Optical Coherence/methods MH - Eye Proteins/genetics OTO - NOTNLM OT - EYS OT - Retinal dystrophies OT - patient-reported outcomes OT - quality of life OT - visual function EDAT- 2023/03/23 06:00 MHDA- 2023/07/12 06:42 CRDT- 2023/03/22 07:02 PHST- 2023/07/12 06:42 [medline] PHST- 2023/03/23 06:00 [pubmed] PHST- 2023/03/22 07:02 [entrez] AID - 10.1080/13816810.2023.2191708 [doi] PST - ppublish SO - Ophthalmic Genet. 2023 Aug;44(4):334-340. doi: 10.1080/13816810.2023.2191708. Epub 2023 Mar 22.